Clinical Trials in Pennsylvania

Showing 2321-2340 of 9,383 trials

Fresh Food Farmacy: A Randomized Controlled Trial

NCT03718832

This trial investigates the value created by the highly innovative Fresh Food Farmacy (FFF) program at Geisinger Health. The program provides food-insecure diabetics with healthy food for their entire household: at least two meals per day, five days a week. The program also provides education on how to prepare the food, and education on healthy living including diabetes self management. The research measures the effects of the FFF program on patient health and wellbeing.

Type 2 Diabetes

John B Bulger, DO500 participantsStarted Apr 2019

Lewistown, Pennsylvania, United States • Scranton, Pennsylvania, United States

COMPLETEDPhase 336 miles

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

NCT04411199

Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to Assess Efficacy and Safety of D-PLEX Administered Concomitantly with the Standard of Care (SoC), Compared to a SoC Treated Control Arm, in Prevention of Post Abdominal Surgery Incisional Infection.

Surgical Site InfectionColon SurgeryAbdominal Surgery+1 more

PolyPid Ltd.800 participantsStarted Dec 2020

Augusta, Georgia, United States • New Orleans, Louisiana, United States • St Louis, Missouri, United States +55 more locations

Fresh Food Farmacy: A Randomized Controlled Trial

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

Find Trials by Condition in Pennsylvania

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

AVID100 in Advanced Epithelial Carcinomas

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

ALL Adult Consortium Trial: Adult ALL Trial

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease